Literature DB >> 21090929

Hypertension alone or related to the metabolic syndrome in postmenopausal women.

Annachiara Nuzzo1, Rosario Rossi, Maria Grazia Modena.   

Abstract

Cardiovascular risk is poorly perceived by women, especially during the peri- and postmenopausal period when susceptibility to cardiovascular events increases. Nevertheless in Europe, 55% of women versus 43% of men currently die of cardiovascular disease. Blood pressure is one of the most powerful and accurate determinants of cardiovascular status and risk. Despite its importance, hypertension is often underestimated and undiagnosed, especially in women. Various mechanisms are implicated to play a role in the blood pressure increase in women at the time of menopause. Hypertension can be considered an isolated disease, more typical of elderly women, or part of the metabolic syndrome, more frequent in early postmenopausal women. The metabolic syndrome, a clustering of lipid and nonlipid cardiovascular risk factors, is estimated to affect approximately 20-30% of the middle-aged population and its prevalence appears to be increasing in the worldwide population.

Entities:  

Mesh:

Year:  2010        PMID: 21090929     DOI: 10.1586/erc.10.147

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  8 in total

Review 1.  Gender Differences in Epidemiology, Pathophysiology, and Treatment of Hypertension.

Authors:  Paolo Di Giosia; Paolo Giorgini; Cosimo Andrea Stamerra; Marco Petrarca; Claudio Ferri; Amirhossein Sahebkar
Journal:  Curr Atheroscler Rep       Date:  2018-02-14       Impact factor: 5.113

2.  Prevalence of pre-hypertension and hypertension, awareness, treatment, and control of hypertension, and cardiovascular risk factors in postmenopausal women.

Authors:  Maryam Eghbali-Babadi; Alireza Khosravi; Awat Feizi; Hassan Alikhasi; Narges Kheirollahi; Nizal Sarrafzadegan
Journal:  ARYA Atheroscler       Date:  2021-09

3.  Hypertension in women: latest findings and clinical implications.

Authors:  Helga Gudmundsdottir; Aud Høieggen; Aud Stenehjem; Bård Waldum; Ingrid Os
Journal:  Ther Adv Chronic Dis       Date:  2012-05       Impact factor: 5.091

Review 4.  Gender disparities in midlife hypertension: a review of the evidence on the Arab region.

Authors:  Christelle Akl; Chaza Akik; Hala Ghattas; Carla Makhlouf Obermeyer
Journal:  Womens Midlife Health       Date:  2017-05-04

5.  Hemodynamic and metabolic effects of estrogen plus progestin therapy in hypertensive postmenopausal women treated with an ACE-inhibitor or a diuretic.

Authors:  Anna Posadzy-Malaczynska; Katarzyna Rajpold; Lucyna Woznicka-Leskiewicz; Justyna Marcinkowska
Journal:  Clin Res Cardiol       Date:  2014-09-13       Impact factor: 5.460

6.  Metabolic syndrome in hypertensive women in the age of menopause: a case study on data from general practice electronic health records.

Authors:  Šefket Šabanović; Majnarić Trtica Ljiljana; František Babič; Michal Vadovský; Ján Paralič; Aleksandar Včev; Andreas Holzinger
Journal:  BMC Med Inform Decis Mak       Date:  2018-04-02       Impact factor: 2.796

7.  The Effect of Hypertension Duration and the Age of Onset on CV Risk Factors Expression in Perimenopausal Women.

Authors:  Ljiljana Trtica Majnarić; Ivo Martinović; Šefket Šabanović; Stjepan Rudan; František Babič; Thomas Wittlinger
Journal:  Int J Hypertens       Date:  2019-12-09       Impact factor: 2.420

8.  Clustering Inflammatory Markers with Sociodemographic and Clinical Characteristics of Patients with Diabetes Type 2 Can Support Family Physicians' Clinical Reasoning by Reducing Patients' Complexity.

Authors:  Zvonimir Bosnic; Pinar Yildirim; František Babič; Ines Šahinović; Thomas Wittlinger; Ivo Martinović; Ljiljana Trtica Majnaric
Journal:  Healthcare (Basel)       Date:  2021-12-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.